{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:21:25Z","timestamp":1756894885422,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Evidence on the effect of self-protection via social distancing and wearing face-masks on infections during chemotherapy is currently not available. We asked if the occurrence of acute infections during chemotherapy for advanced-stage Hodgkin lymphoma (HL) decreased when COVID-19 protection measures were in effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed the occurrence of infections during all documented eBEACOPP cycles starting between 01 March and 30 June of 2017 to 2020 in patients treated within the GHSG HD21 study in Germany and compared the infection rates and characteristics by logistic regression models and means of descriptive statistics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We analyzed 911 cycles of 313 adult patients treated with 4 to 6 cycles of eBEACOPP. We found a significant decrease in the occurrence of infections during chemotherapy for HL during COVID-19 lockdown from 131 (19.6%) of 670 cycles in 2017\u20132019 to 30 (12.6%) of 239 cycles during COVID-19 lockdown [OR 0.574 (95% CI 0.354\u20130.930), <jats:italic>P<\/jats:italic>\u2009=\u20090.024]. The strongest effect was evident for unspecified infections with 39 cycles (5.8%) during 2017\u20132019 in comparison to 5 cycles (2.1%) during COVID-19 lockdown. 20 (24.1%) of 83 patients had an infection during the COVID-19 lockdown versus 99 (43.2%) of 229 patients in the years 2017\u20132019 (<jats:italic>P<\/jats:italic>\u2009=\u20090.0023).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The significant decrease of infections during chemotherapy for HL during COVID-19 lockdown reveals the protective measures\u2019 potential to shield patients from transmissible pathogens. We conclude that these measures could be recommended for HL patients at risk for infections during chemotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s15010-022-01765-3","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T12:04:21Z","timestamp":1645272261000},"page":"925-932","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma"],"prefix":"10.1007","volume":"50","author":[{"given":"Anne Sophie","family":"Jacob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Gillessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Kreissl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Pluetschow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesko","family":"Momotow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdete","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Huettmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Haenel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Dierlamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Mathas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,19]]},"reference":[{"key":"1765_CR1","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1056\/NEJMoa022473","volume":"348","author":"V Diehl","year":"2003","unstructured":"Diehl V, Franklin J, Pfreundschuh M, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin\u2019s disease. N Engl J Med. 2003;348:2386\u201395.","journal-title":"N Engl J Med"},{"key":"1765_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ncponc1186","volume":"5","author":"AM Evens","year":"2008","unstructured":"Evens AM, Hutchings M, Diehl V. Treatment of Hodgkin lymphoma: the past, present, and future. Nat Clin Pract Oncol. 2008;5:543\u201356.","journal-title":"Nat Clin Pract Oncol"},{"key":"1765_CR3","first-page":"CD004386","volume":"1","author":"A Gafter-Gvili","year":"2012","unstructured":"Gafter-Gvili A, Fraser A, Paul M, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev. 2012;1:CD004386.","journal-title":"Cochrane Database Syst Rev"},{"key":"1765_CR4","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/HS9.0000000000000005","volume":"1","author":"A Engert","year":"2017","unstructured":"Engert A, Goergen H, Markova J, et al. Reduced-intensity chemotherapy in patients with advanced-stage Hodgkin lymphoma: updated results of the open-label, international, randomised phase 3 HD15 trial by the German Hodgkin study group. Hemasphere. 2017;1:e5.","journal-title":"Hemasphere"},{"key":"1765_CR5","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1200\/JCO.18.00374","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol. 2018;36:3043\u201354.","journal-title":"J Clin Oncol"},{"key":"1765_CR6","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, et al. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006;106:2258\u201366.","journal-title":"Cancer"},{"key":"1765_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1200\/JCO.2014.57.2347","volume":"33","author":"A Carmona-Bayonas","year":"2015","unstructured":"Carmona-Bayonas A, Jimenez-Fonseca P, Virizuela Echaburu J, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015;33:465\u201371.","journal-title":"J Clin Oncol"},{"key":"1765_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","volume":"14","author":"LR Baden","year":"2016","unstructured":"Baden LR, Swaminathan S, Angarone M, et al. Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14:882\u2013913.","journal-title":"J Natl Compr Cancer Netw"},{"key":"1765_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/17474086.2020.1793666","volume":"13","author":"M Dalal","year":"2020","unstructured":"Dalal M, Gupta J, Price K, et al. Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review. Expert Rev Hematol. 2020;13:907\u201322.","journal-title":"Expert Rev Hematol"},{"key":"1765_CR10","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","volume":"390","author":"P Borchmann","year":"2018","unstructured":"Borchmann P, Goergen H, Kobe C, et al. PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet. 2018;390:2790\u2013802.","journal-title":"Lancet"},{"key":"1765_CR11","unstructured":"Bundesministerium f\u00fcr Gesundheit D. Coronavirus SARS-CoV-2: Chronik der bisherigen Ma\u00dfnahmen. In Edition Bundesministerium f\u00fcr Gesundheit, Deutschland 2020. https:\/\/www.bundesgesundheitsministerium.de\/coronavirus\/chronik-coronavirus.html."},{"key":"1765_CR12","unstructured":"Robert-Koch-Institut. T\u00e4glicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19) In 12.03.2020 \u2013AKTUALISIERTER STAND F\u00dcR DEUTSCHLAND, Edition 2020. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/2020-03-12-en.pdf?__blob=publicationFile."},{"key":"1765_CR13","unstructured":"World-Health-Organisation. Novel Coronavirus(2019-nCoV) Situation Report \u2013 22. In Edition 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/330991."},{"key":"1765_CR14","unstructured":"Presseamt und Informationsamt der Bundesregierung D. Maskenpflicht in ganz Deutschland. In Edition Presse- und Informationsamt der Bundesregierung Deutschland 2020. https:\/\/www.bundesregierung.de\/breg-de\/themen\/coronavirus\/maskenpflicht-in-deutschland-1747318."},{"key":"1765_CR15","unstructured":"Robert-Koch-Institut. Robert Koch-Institut: COVID-19-Dashboard. In Edition Berlin: 2020. https:\/\/experience.arcgis.com\/experience\/478220a4c454480e823b17327b2bf1d4."},{"key":"1765_CR16","unstructured":"Robert-Koch-Institut. T\u00e4glicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19) 28.10.2020\u2014aktualisierter stand f\u00fcr deutschland. In Edition 2020. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Okt_2020\/2020-10-28-de.pdf?__blob=publicationFile."},{"key":"1765_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00716-18","author":"N Sundell","year":"2019","unstructured":"Sundell N, Andersson LM, Brittain-Long R, et al. PCR detection of respiratory pathogens in asymptomatic and symptomatic adults. J Clin Microbiol. 2019. https:\/\/doi.org\/10.1128\/JCM.00716-18.","journal-title":"J Clin Microbiol"},{"key":"1765_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.idh.2019.08.006","volume":"25","author":"AS Carvalho","year":"2020","unstructured":"Carvalho AS, Lagana D, Catford J, et al. Bloodstream infections in neutropenic patients with haematological malignancies. Infect Dis Health. 2020;25:22\u20139.","journal-title":"Infect Dis Health"},{"key":"1765_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jiph.2018.12.006","volume":"12","author":"JA Al-Tawfiq","year":"2019","unstructured":"Al-Tawfiq JA, Hinedi K, Khairallah H, et al. Epidemiology and source of infection in patients with febrile neutropenia: a ten-year longitudinal study. J Infect Public Health. 2019;12:364\u20136.","journal-title":"J Infect Public Health"},{"key":"1765_CR20","unstructured":"Kaiser R, Amas O. Aktivit\u00e4t respiratorischer Viren. In Edition Clinical Virology Network. https:\/\/clinical-virology.net\/de\/charts\/chart\/ctype\/count\/network\/resp\/section\/viruses."},{"key":"1765_CR21","doi-asserted-by":"publisher","first-page":"m1628","DOI":"10.1136\/bmj.m1628","volume":"369","author":"KH Chan","year":"2020","unstructured":"Chan KH, Lee PW, Chan CY, et al. Monitoring respiratory infections in covid-19 epidemics. BMJ. 2020;369:m1628.","journal-title":"BMJ"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-022-01765-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01765-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T08:21:33Z","timestamp":1659082893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-022-01765-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,19]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1007\/s15010-022-01765-3","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"type":"print","value":"0300-8126"},{"type":"electronic","value":"1439-0973"}],"subject":[],"published":{"date-parts":[[2022,2,19]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}